Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Laboratory Services

 

Medlife reveals sub-sector impact as summer activity normalises

Listed Romanian operator Medlife's H1 results partially reveal how the national lockdown affected its hospital, lab, dentistry, outpatient, pharmacy and corporate businesses. HBI analysis and investigation reveals the Q2 segment figures and the factors behind average price increases partially offseting sharp volume drops.
August 20, 2020

Biogroup makes first acquisition outside of France – and plans more

Biogroup, France's largest lab group by revenue, has new Belgian shareholders after it acquired family-owned CMA-Medina, its first move outside of the home market. CEO Stephane Eimer tells HBI that the new Franco-Belgian group will make more acquisitions there and abroad.
August 17, 2020

Adding value post-COVID – where are the easy wins?

How do you add value to a business in a post COVID world - and are there any easy wins for new acquisitions? On Wednesday last week, an online audience heard HBI365's lively Q&A panel with with Ameos CEO Dr Axel Paeger, McKinsey partner Sebastian Sieler, and L Catterton managing partner Chinta Bhagat.
July 23, 2020

Interview: Arjan Toor, CEO, Cigna Europe

Cigna now describes itself as “a global health service company” rather than an insurer and has reorganised its European operations. Toor has recently been promoted to CEO Europe. He says that the insurer, which has 15% (US$840m) of its revenue in Europe, doesn't want to verticalise through owning primary care providers but wants instead to provide an end-to-end user experience.
July 21, 2020

Health care values look high

Analyst forecasts suggest that healthcare sector valuations have been largely unaffected by the crisis, with EMEA hospitals and medtech stocks now being more expensive than before the Covid outbreak, both on an EBITDA and PE multiples basis.
June 29, 2020

Could Synlab’s UK success open the outsourcing floodgates?

UK lab group Viapath has been nationalised, after Guy's and St Thomas' and King's College Hospital NHS Foundation Trusts bought out its private sector partner Serco following the loss of a £2.25bn outsourcing contract in which Synlab remains the preferred bidder. Could Synlab's expected success be the first of a slew of new outsourcing contracts for big lab platforms? HBI talks to a consultant to find out more.
June 23, 2020

Labs bounce back and eye opportunities

A v-shaped recovery, new markets, new customers, new entrants, new technology and the ear of big government: the HBI 2020 diagnostics panel discussion reveals new opportunities.
June 11, 2020
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us